Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Blood Cell Therapy|June 8, 2026
Peripheral Nerve Infiltration by CAR T-cells in a Case of Mononeuritis Multiplex after Ciltacabtagene AutoleucelHitomi Hosoya, Kun-Wei Song, Kyle Dyson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasisEleonora Dondossola, Roberto Rangel, Liliana Guzman-Rojas, et al.
Blood Advances|July 23, 2024
Clinical outcomes after idecabtagene vicleucel in older patients with multiple myeloma: a multicenter real-world experienceNilesh M Kalariya, Michelle A T Hildebrandt, Doris K Hansen, et al.
Nature Communications|February 20, 2025
Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myelomaHitomi Hosoya, Mia Carleton, Kailee Tanaka, et al.
Blood|November 25, 2025
Long-term Follow-up of Gastrointestinal CAR T-cell Lymphoma: Homing, Clonal Expansion, and Response to CyclosporineHitomi Hosoya, Armando N Bastidas Torres, Sebastian Fernandez-Pol, et al.
Nature Communications|April 19, 2012
Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cellsRoberto Rangel, Liliana Guzman-Rojas, Lucia G le Roux, et al.
Transplantation and Cellular Therapy|August 29, 2025
The Impact of Anti-CD38 Monoclonal Antibody Therapy on Stem-Cell Mobilization Yields in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Referred from Community and Academic Oncology Practices: Single Center, Real World Data 2021-2024Dilek Uzun, Jeddeo Michael Paul, Alexandria Jensen, et al.
Transplantation and Cellular Therapy|March 27, 2026
Superior Chronic GVHD-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell TransplantationAlfonso Molina, Quenton Rashawn Bubb, Hrishikesh K Srinagesh, et al.
Blood Cancer Journal|October 9, 2024
Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myelomaSurbhi Sidana, Andriyana K Bankova, Hitomi Hosoya, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2016
Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo releaseHitomi Hosoya, Andrey S Dobroff, Wouter H P Driessen, et al.
Pageof 4